Member Info for JOHNO77

Hardly any point when you can buy just over 9p in open market

Yep, think this will be much higher at some point in next few months

Good opp to buy below 1.2

Nice update

Very decent 6month update there.

£1.7m cash

Building from the excellent N101 and SRI collaboration results, N4 is now very well poised with current team to complete the data set to open up deals with commercial partners.

Migrating from UQ to more specialist CMAC @ Strathclyde - an excellent move

Yep a few half decent buys going though

Don't think so, they raised cash no more than 5 months ago

6month results out tomorrow so cash will be there to see

Great day for N4P. Look forward to reading more in the scheduled results on Thursday.

Junior pharmas doing very well at the mo, could we be at the beginning of a re rate here?

We had not heard much on it recently but good to see the SRI work still very active indeed

Yes great update there

Look at Immupharma (IMM). It looked like a dead duck for years and was at the micro cap of N4P. It has leapt to £75mcap on the back of successful preclinical research.

Things can change very very quickly. That’s why we are here.

Our Commercial Director Dr. Simon Bennett will be attending RNA Leaders USA, taking place in Boston on September 10-11 2025. Simon will be available to connect, exchange insights and explore the emerging innovations in the hashtag#RNA space. Set up a meeting with him: https://lnkd.in/e-6_X_cJ

Https://www.linkedin.com/posts/n4-pharma-plc_rna-rnaleaders-rnaleadersusa-activity-7371090044188532737-GI8b?utm_medium=ios_app&rcm=ACoAAAzo_e0B8gwxbMM-6kLJloyT_78jDNTljhg&utm_source=social_share_send&utm_campaign=share_via

I did jump ship for a short while but now back here. Look how Aptamer and IMM amongst others pharmas have rallied recently. Yes Aptamer have had v strong newsflow but it shows what can happen to these tiddlers with a bit of momentum. They surely have enough bods in the back room now to get things moving.

Finally starting to move in the right direction!?

Cracking stuff. Am just glad i jumped ship last month from N4P into APTA, a company who walk the walk, not just talk the talk. A rarity on AIM.

That's the holy grail effect mate....

...or maybe they just have deployed their own management team to ensure the job gets done.

Agreed Homer. You'd think Tracarta Limited would not have chucked that much in without certain assurances or confidence that things are likely to improve for N4

6-7 directors / senior managers required to conduct a couple of test tube experiments a year.

Let's hope the new appointments mean that they anticipate having to do a bit more work than that in 2025...

...Market not impressed anyway, so need more updates with substance, and less of the window dressing.